dc.contributor.author |
Idindili, B. |
|
dc.contributor.author |
Minzi, O. |
|
dc.contributor.author |
Rumisha, S.F. |
|
dc.contributor.author |
Mugusi, F. |
|
dc.contributor.author |
Tanner, M. |
|
dc.date.accessioned |
2013-02-06T10:07:46Z |
|
dc.date.available |
2013-02-06T10:07:46Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
Boniphace, I., Omari, M., Fred, R. S., Ferdinand, M., & Marcel, T. (2011). HIV/AIDS clinical manifestations and their implication for patient clinical staging in resource limited settings in Tanzania. The open AIDS journal, 5, 9. |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/164 |
|
dc.description.abstract |
Background: Tanzania HIV/AIDS management follows WHO clinical staging which requires CD4 counts as
complement. Lacking CD4 counts facilities in rural health facilities remains a challenge. Simplified and sensitive clinical
staging based on local clinical patterns is useful to ensure effective care without CD4 counts.
Objectives: To assess whether local HIV clinical manifestations can be used to guide HIV management in settings with
limited access to CD4 counts in Tanzania.
Methods: A Cross-sectional study conducted at Tumbi and Chalinze health facilities documented clinical manifestations
and CD4 counts in 360 HIV/AIDS patients. Simplified management groups comprised of severe and moderate disease
were formed based on clinical manifestations and CD4 counts results. Symptoms with high frequency were used to
predict severe disease.
Results: Weight loss (48.3%) and chronic cough (40.8 %) were the most reported manifestations in the study population.
More than 50% of patients presented with CD4200. Most symptoms were found to be highly sensitive (71% to 93%) in
predicting severe immunosuppression using CD4<200 cut-off point as a ‘Gold standard’. Chronic diarrhoea presented in
10.6%, and predicted well severe immunosuppression either alone (OR 1.95, 95%CI, 0.95-4.22) or in combination (OR
4.21, 95%CI 0.92-19.33) with other symptoms. Basing strictly on WHO clinical staging 30.8% of patients were detected
to be severely immunosuppressed (Stage 4). While using our proposed management categories of severe and moderate
immunosuppression 70% of patients were put into the severe immunosuppression group, consistent with CD4 cut-off
count of350.
Conclusions: HIV/AIDS clinics managing large cohorts should develop validated site specific guidelines based on local
experiences. Simplified guidelines are useful for resource constrained settings without CD4 counting facilities. |
en_GB |
dc.language.iso |
en |
en_GB |
dc.publisher |
The Open AIDS Journal |
en_GB |
dc.publisher |
Muhimbili University of Health and Allied Sciences |
|
dc.relation.ispartofseries |
The Open AIDS Journal;5, 9-16 |
|
dc.subject |
HIV |
en_GB |
dc.subject |
AIDS |
en_GB |
dc.subject |
clinical manifestation |
en_GB |
dc.subject |
staging |
en_GB |
dc.subject |
peripheral |
en_GB |
dc.subject |
Tanzania |
en_GB |
dc.title |
HIV/AIDS Clinical Manifestations and their Implication for Patient Clinical Staging in Resource Limited Settings in Tanzania |
en_GB |
dc.type |
Article |
en_GB |